Many breast cancer survivors are menopausal either at diagnosis or as a result of a premature therapy-induced menopause, complaining frequently of climacteric symptoms . The menopause is widely seen as part of the natural ageing process; however, for many women who have had treatment for breast cancer; it can be viewed as a further complication, which can significantly impact on their quality of life as they recover from cancer treatment . The increased symptoms often coincide with a time of transition from the completion of intensive treatment to follow-up care when there can be a perceived decrease in levels of support . The limited evidence to guide practice both pharmacologically and nonpharmacologically within breast cancer has created a confused environment, for both clinicians and patients . The aim of the present study was therefore to explore the experiences and expectations of both women with breast cancer and the health professionals, in relation to the management of menopausal symptoms in a clinical setting.